Adocia

ADOC · Euronext Paris · France

Public Market Listing

ADOCEuronext Paris

Euronext Paris primary exchange listing

Live quotes, historical charts, and market capitalization for Adocia are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Phase 3
Insulin receptorPeptide
Type 2 Diabetes

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Regulatory and conference events

(2)

Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.

Recent

15 October 2025Topline resultTHDB0206THDB0206 Phase 3 in T1D (NCT07282054) met its primary endpoint
Adocia · Source ↗
25 July 2025Topline resultTHDB0206THDB0206 Phase 3 in T2D (NCT05834868) met its primary endpoint
Adocia · Source ↗

Financial reports

No financial reports recorded.